We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$168M
AUM Growth
-$47.9M
Cap. Flow
-$34.3M
Cap. Flow %
-20.4%
Top 10 Hldgs %
60.49%
Holding
95
New
8
Increased
17
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$5.12M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.13M
3
RLMD icon
Relmada Therapeutics
RLMD
+$2.08M
4
ARDX icon
Ardelyx
ARDX
+$1.37M
5
TGTX icon
TG Therapeutics
TGTX
+$1.34M

Top Sells

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$44M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$1.64M
3
TECX
Tectonic Therapeutic
TECX
+$1.54M
4
TVTX icon
Travere Therapeutics
TVTX
+$1.36M
5
BHVN icon
Biohaven
BHVN
+$1.25M

Sector Composition

Rank Sector Weight
1 Healthcare 53.57%
2 Financials 19.49%
3 Communication Services 15.66%
4 Technology 1.31%
5 Energy 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LENZ
51
LENZ Therapeutics
LENZ
$145M
$309K 0.18%
33,732
-20,000
-37% -$281K
WVE icon
52
Wave Life Sciences
WVE
$1.02B
$290K 0.17%
40,000
-50,000
-56% -$651K
RAIN
53
Rain Enhancement Technologies
RAIN
$10M
$258K 0.15%
+101,686
New +$296K
KMB icon
54
Kimberly-Clark
KMB
$36.8B
$232K 0.14%
2,400
– –
NVDA icon
55
NVIDIA
NVDA
$5.46T
$223K 0.13%
1,280
– –
RHP icon
56
Ryman Hospitality Properties
RHP
$7.87B
$221K 0.13%
2,400
– –
AVGO icon
57
Broadcom
AVGO
$1.99T
$220K 0.13%
710
– –
MDLZ icon
58
Mondelez International
MDLZ
$81.1B
$173K 0.1%
3,000
– –
DD icon
59
DuPont de Nemours
DD
$19.5B
$173K 0.1%
1,256
– –
JSPR icon
60
Jasper Therapeutics
JSPR
$28.7M
$141K 0.08%
160,789
-20,600
-11% -$28.6K
IVVD icon
61
Invivyd
IVVD
$202M
$130K 0.08%
100,000
– –
CTVA icon
62
Corteva
CTVA
$50.6B
$101K 0.06%
1,206
– –
MREO
63
Mereo BioPharma
MREO
$49.1M
$99.1K 0.06%
300,337
– –
EBC icon
64
Eastern Bankshares
EBC
$5.37B
$97.8K 0.06%
5,000
– –
PWR icon
65
Quanta Services
PWR
$101B
$96.6K 0.06%
176
– –
IWP icon
66
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
$89K 0.05%
695
– –
GOOGL icon
67
Alphabet (Google) Class A
GOOGL
$4.24T
$86.3K 0.05%
300
– –
LEGH icon
68
Legacy Housing
LEGH
$692M
$81.7K 0.05%
4,000
– –
AMZN icon
69
Amazon
AMZN
$2.86T
$62.5K 0.04%
300
– –
URI icon
70
United Rentals
URI
$69.7B
$56.8K 0.03%
78
– –
DOW icon
71
Dow Inc
DOW
$21.9B
$50.2K 0.03%
1,206
– –
OXY icon
72
Occidental Petroleum
OXY
$57.7B
$34.7K 0.02%
663
– –
DHR icon
73
Danaher
DHR
$143B
$34.1K 0.02%
180
– –
BRSL
74
Brightstar Lottery PLC
BRSL
$2.15B
$31.9K 0.02%
2,500
– –
FSK icon
75
FS KKR Capital
FSK
$3.49B
$29.3K 0.02%
2,875
– –
1 2
3
4

Similar funds

SF
Steffes Financial Overland Park, Kansas $189M AUM
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
BC
Beaconlight Capital New York $190M AUM 95.82% 1-Year Est. Return
CFA
Camarda Financial Advisors Fleming Island, Florida $190M AUM 48.71% 1-Year Est. Return
HCM
Harspring Capital Management New York $190M AUM 19.3% 1-Year Est. Return
RCAP
Resolute Capital Asset Partners Denver, Colorado $190M AUM 160.65% 1-Year Est. Return
AAA
American Alpha Advisors New York $188M AUM 42.65% 1-Year Est. Return
CCM
Clearfield Capital Management New York $188M AUM 84.86% 1-Year Est. Return

David M. Knott Jr's Q1 2026 Portfolio in Review

As of Q1 2026, David M. Knott Jr held 95 positions worth $168M, down 22% from $216M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $34.3M in Q1 2026, closing 10 positions and reducing 13 holdings. Its most notable exit was Calumet Specialty Products, an estimated $44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 41% a quarter earlier, followed by Financials and Communication Services.

Against the trend, David M. Knott Jr opened a new position in Iovance Biotherapeutics worth $5.62M.

  • David M. Knott Jr's largest Q1 2026 buy was Iovance Biotherapeutics: 1,600,000 shares worth $5.62M.
  • David M. Knott Jr added most to Agios Pharmaceuticals in Q1 2026, an estimated $2.13M increase.
  • David M. Knott Jr's biggest Q1 2026 reduction was Catalyst Pharmaceutical, cutting an estimated $1.64M.
  • David M. Knott Jr fully exited Calumet Specialty Products in Q1 2026, selling an estimated $44M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $168M portfolio in Q1 2026.
  • David M. Knott Jr opened 8 new positions and closed 10 in Q1 2026.
  • David M. Knott Jr's portfolio value fell 22% quarter-over-quarter to $168M.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.